PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities

PCR-based PoC Platforms for Infectious Disease Testing Growth Opportunities

Multimodal and Multiplex Platforms are Expanding the Molecular PoC Testing Ecosystem

RELEASE DATE
19-Dec-2022
REGION
North America
Deliverable Type
Market Research
Research Code: PD26-01-00-00-00
SKU: HC03619-NA-MT_27287
AvailableYesPDF Download
$2,450.00
In stock
SKU
HC03619-NA-MT_27287
$2,450.00
DownloadLink
ENQUIRE NOW

Description

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respiratory tract pathogens are noteworthy. The dynamic exemplifies industry participants carving new growth vectors and converging to better manage business units and patient populations.

With rapid advancements in consumer access to diagnostic tests, the in vitro diagnostic (IVD) industry will bridge gaps in care and deliver a seamless and convenient consumer experience. Superior sensor performance, short turnaround times, low system complexity, compact designs, seamless data transmission, and minimized user intervention are essential features of scalable PCR-based PoC platforms.

As multiplexing continues to prove its benefits to patients and public health, it induces an important shift in diagnostic and surveillance efforts (that is, the shift from high-priority samples to comprehensive testing of large samples). With improvements in throughput capabilities, sample-to-answer PoC platforms will inspire the development of the multimodal IVD testing ecosystem.

Author: Amartya Bose

Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the PCR-based PoC Platforms for the Infectious Disease Testing Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope

Growth Environment

Competitive Landscape

Competitive Landscape (continued)

Competitive Landscape (continued)

Competitive Landscape (continued)

Growth Drivers

Growth Restraints

Growth Opportunity 1: Multimodal and Multiplex Platforms

Growth Opportunity 1: Multimodal and Multiplex Platforms (continued)

Growth Opportunity 2: Platform Connectivity

Growth Opportunity 2: Platform Connectivity (continued)

List of Exhibits

Legal Disclaimer

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respiratory tract pathogens are noteworthy. The dynamic exemplifies industry participants carving new growth vectors and converging to better manage business units and patient populations. With rapid advancements in consumer access to diagnostic tests, the in vitro diagnostic (IVD) industry will bridge gaps in care and deliver a seamless and convenient consumer experience. Superior sensor performance, short turnaround times, low system complexity, compact designs, seamless data transmission, and minimized user intervention are essential features of scalable PCR-based PoC platforms. As multiplexing continues to prove its benefits to patients and public health, it induces an important shift in diagnostic and surveillance efforts (that is, the shift from high-priority samples to comprehensive testing of large samples). With improvements in throughput capabilities, sample-to-answer PoC platforms will inspire the development of the multimodal IVD testing ecosystem. Author: Amartya Bose
More Information
Deliverable Type Market Research
Author Amartya Bose
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Infectious Disease Point-of-care (POC) Diagnostics Market
Keyword 2 PCR-based diagnostics for infectious diseases
Keyword 3 Paper-Based Point-of-Care Testing
Podcast No
WIP Number PD26-01-00-00-00